Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ProdromeNeuro: A Phase I Study of Omega 3 Oil Nutritional Supplementation for Aging-Related Cognitive Decline

NCT05041088 is registered in ClinicalTrials.gov with Neurological Associates of West Los Angeles as lead sponsor.

NCT NCT05041088
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05041088 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ProdromeNeuro: A Phase I Study of Omega 3 Oil Nutritional Supplementation for Aging-Related Cognitive Decline
Lead sponsor
Neurological Associates of West Los Angeles
Phase
Phase 1
Overall status
Unknown status
Start date
June 20, 2023
Completion date
November 20, 2023
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

aging related cognitive decline